4.7 Article

Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach

Journal

BIOMEDICINE & PHARMACOTHERAPY
Volume 141, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2021.111940

Keywords

Liquid crystalline nanoparticles; Quality by design; Relative risk-based matrix analysis; Quality risk management; Design of experiments

Ask authors/readers for more resources

The combination of lipid-based nanoparticles and lyotropic liquid crystals has resulted in the creation of a new type of nano carrier system called 'lipid-based lyotropic liquid crystals' or 'liquid crystalline nanoparticles' (LCNPs). By utilizing the quality by design (QbD) approach in the formulation of LCNPs, many unique advantages can be achieved, such as better understanding of the product and process, flexibility within the design space, effective control strategies, easy transfer from bench to bedside, and a more robust product. This work explores the application of QbD elements in the formulation of LCNPs, providing a detailed explanation with case studies and offering a foundation for QbD-driven formulation of LCNPs with a regulatory perspective.
The intersection of lipid-based nanoparticles and lyotropic liquid crystals has provided a novel type of nano carrier system known as 'lipid-based lyotropic liquid crystals' or 'liquid crystalline nanoparticles' (LCNPs). The unique advantages and immense popularity of LCNPs can be exploited in a better way if the formulation of LCNPs is done using the approach of quality by design (QbD). QbD is a systematic method that can be utilized in formulation development. When QbD is applied to LCNPs formulation, it will proffer many unique advantages, such as better product and process understanding, the flexibility of process within the design space, implementation of more effective and efficient control strategies, easy transfer from bench to bedside, and more robust product. In this work, the application of QbD in the formulation of LCNPs has been explored. The elements of QbD, viz. quality target product profile, critical quality attributes, critical material attributes, critical process parameters, quality risk management, design of experiments, and control strategy for the development of LCNPs have been explained in-depth with case studies. The present work will help the reader to understand the nittygritties in the application of QbD in the formulation of LCNPs, and provide a base for QbD-driven formulation of LCNPs with a regulatory perspective.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available